Mirati Therapeutics Inc. buy melinda
Start price
15.10.17
/
50%
€14.50
Target price
16.10.17
€14.50
Performance (%)
0.69%
End price
16.10.17
€14.60
Summary
This prediction ended on 16.10.17 with a price of €14.60. The BUY prediction by melinda for Mirati Therapeutics Inc. closed nearly unchanged. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Mirati Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
Comments by melinda for this prediction
In the thread Mirati Therapeutics Inc. diskutieren
Phase 2 Poster werden auf der Weltkonferenz für Lungenkrebs 16 bis 18. Oktober 2017 erwartet.
(Zielkurs erreicht)
Stopped prediction by melinda for Mirati Therapeutics Inc.
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€95.50
26.11.22
26.11.22
-
26.11.23
26.11.23
-45.74%
27.11.23
27.11.23
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€121.45
21.08.20
21.08.20
€130.00
04.11.21
04.11.21
19.06%
05.11.21
05.11.21
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€56.64
05.05.19
05.05.19
€69.45
11.06.19
11.06.19
55.44%
11.06.19
11.06.19
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€27.96
07.03.18
07.03.18
€29.77
09.03.18
09.03.18
6.94%
09.03.18
09.03.18
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€13.08
15.10.17
15.10.17
€13.08
16.10.17
16.10.17
0.69%
16.10.17
16.10.17
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.90
12.04.17
12.04.17
€4.69
26.04.17
26.04.17
7.51%
26.04.17
26.04.17
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.15
13.06.16
13.06.16
€10.37
13.12.16
13.12.16
-28.12%
13.12.16
13.12.16